Neuronetics, a medical device company, agreed to acquire Greenbrook, a mental health services centre operator. Financial terms were not disclosed. “This transaction combines two organizations who share a common mission to better care for the growing number of patients who are suffering from mental health conditions, many of whom are poorly served by medication alone. By combining Neuronetics’ innovative NeuroStar platform as well as their education and training expertise, with Greenbrook’s well established practice operations and support capabilities, we believe the combined company can improve care at Greenbrook’s existing sites and, just as importantly, at any practice across the country that is looking to bring the benefits of NeuroStar to their patients,” Bill Leonard, Greenbrook President and CEO.